Erhöhte basale Serumtryptasekonzentration oder Mastozytose als Risikofaktor der Hymenopterengiftallergie Leitlinie der Deutschen Gesellschaft für Allergologie und Klinische Immunologie (DGAKI) (AWMF-Leitlinie 061/018) / Elevated basal serum tryptase concentration or mastocytosis as a risk factor in Hymenoptera venom allergy (AWMF-Guideline 061/018)

2007 ◽  
Vol 31 (5) ◽  
pp. 214-217
Author(s):  
Bernhard Przybilla ◽  
Ulrich Müller ◽  
Reinhart Jarisch ◽  
Franziska Ruëff
Keyword(s):  
Risk Factor ◽  
Hymenoptera Venom ◽  
Venom Allergy ◽  
Serum Tryptase ◽  
Hymenoptera Venom Allergy ◽  
Basal Serum

Shortness of interval between two stings as risk factor for developing Hymenoptera venom allergy

Allergy ◽  
1994 ◽  
Vol 49 (10) ◽  
pp. 894-896 ◽  
Author(s):  
S. Pucci ◽  
L. Antonicelli ◽  
M. B. Bilò ◽  
M. S. Garritani ◽  
F. Bonifazi
Keyword(s):  
Risk Factor ◽  
Hymenoptera Venom ◽  
Venom Allergy ◽  
Hymenoptera Venom Allergy

scholarly journals Clonal mast cell disorders in patients with severe Hymenoptera venom allergy and normal serum tryptase levels

2015 ◽  
Vol 136 (1) ◽  
pp. 135-139 ◽  
Author(s):  
Roberta Zanotti ◽  
Carla Lombardo ◽  
Giovanni Passalacqua ◽  
Cristian Caimmi ◽  
Massimiliano Bonifacio ◽  
...  
Keyword(s):  
Mast Cell ◽  
Normal Serum ◽  
Hymenoptera Venom ◽  
Venom Allergy ◽  
Serum Tryptase ◽  
Hymenoptera Venom Allergy

Predictors of side effects during the buildup phase of venom immunotherapy for Hymenoptera venom allergy: The importance of baseline serum tryptase†

2010 ◽  
Vol 126 (1) ◽  
pp. 105-111.e5 ◽  
Author(s):  
Franziska Ruëff ◽  
Bernhard Przybilla ◽  
Maria Beatrice Biló ◽  
Ulrich Müller ◽  
Fabian Scheipl ◽  
...  
Keyword(s):  
Side Effects ◽  
Hymenoptera Venom ◽  
Venom Allergy ◽  
Venom Immunotherapy ◽  
Serum Tryptase ◽  
Hymenoptera Venom Allergy ◽  
Baseline Serum
Sign in / Sign up

Export Citation Format

Share Document